Rural Cancer Care in 2026: More Oncologists, Yet Wider Gaps

A 2026 evidence review points to a troubling mismatch in rural cancer care. Rural residents still face larger differences in cancer rates, how early tumors are found, access to treatment, and death rates. These gaps have continued to grow. The review looked at English-language research published through early 2026, including peer-reviewed studies, national surveillance data, ASCO abstracts, and policy analyses.

Money is a major barrier. About 85% of rural hospitals are considered strained or financially vulnerable. Cancer services at critical access hospitals have also declined. Another problem comes from the 340B Drug Pricing Program, which excludes critical access hospitals from its orphan-drug benefit. That gap can weaken facilities that depend heavily on the program. It raises a basic question: can cancer care remain available when the local health system struggles to survive?

The burden is not spread evenly. Rural and urban cancer death gaps are largest among adults younger than 65, a pattern called the age paradox. People in this age group do not have Medicare’s partial safety net. Rural Black Americans and American Indian/Alaska Natives also face both geographic and structural barriers. Age, location, race, ethnicity, and policy can combine to make care even harder to reach.

The workforce picture challenges older assumptions. From 2012 to 2022, the rural supply of oncologists per person grew by about 20% nationwide. In the most isolated places, it grew by roughly 67%. Promising care models include hub-and-spoke networks, teleoncology, Project ECHO telementoring, critical access hospital programs, patient navigation, oncology hospital-at-home, and National Cancer Institute Community Oncology Research Program sites. Yet another mismatch remains: places with the poorest geographic access to cancer centers have the lowest telehealth use. The evidence frames the problem as one rooted in policy and equity.